Pfizer Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
PFIZER · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
All seven promoter entities of Pfizer Limited — Pfizer East India B.V., Pharmacia LLC, Warner-Lambert Company LLC, Wyeth Holdings LLC, Wyeth LLC, John Wyeth & Brother Limited, and Parke, Davis & Company LLC — have submitted their annual declarations under SEBI Regulation 31(4) for the financial year ended March 31, 2025. Each entity, along with persons acting in concert, confirms that no encumbrance (such as pledge, lien, or charge) was created directly or indirectly on their equity shares in the company during the year. This is a routine year-end compliance filing required of promoters, and the declarations are essentially 'nil' reports.
This is a neutral, routine compliance filing. It reassures shareholders that promoters have not pledged or encumbered any of their shares, meaning no risk of forced selling or margin calls stemming from promoter holdings. No material impact on the stock price is expected.